Autopsy report · NCT06473974
Open-label, Single-arm, Proof of Concept Study in Subjects with Mild-to-moderate Facial Hyperpigmentation
Cause of deathRegulatory or ethics
“This study had been withdrawn by the sponsor as they are in process to approach FDA with rationale to get agency feedback and share written response on IRB query. Thereafter, they may again approach with new application and FDA written response.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- Kayuraeffect, LLP
- Sponsor type
- Industry
- Conditions
- Facial Hyperpigmentation
- Interventions
- Test cosmetic product
- Participants
- 0
- Sites
- 2
- Countries
- United States
Trials that died the same way
- Antibiotics and Tissue Expanders in Breast Reconstruction
“The study was withdrawn prior to IRB approval.” - Impact of Early Diagnosis and Treatment of OSA on Hospital Readmission in Hospitalized COPD Patients
“The study was withdrawn prior to initiation. The protocol was submitted for IRB review but was not approved. No participants were enrolled.” - CPAP Population Management
“The study was withdrawn prior to initiation. The protocol was submitted for IRB review but was not approved, and no participants were enrolled.” - RCT Investigating Pre-cesarean Vaginal Wash of Chlorhexidine vs Povidone-iodine for Patient With Ruptured Amniotic Membrane.
“The study was withdrawn from the IRB” - iNOPulse for COVID-19
“IRB AND FDA REVIEWS DEFERRED”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.